Adams Wealth Management Buys Shares of 2,070 CME Group Inc. $CME

Adams Wealth Management bought a new position in shares of CME Group Inc. (NASDAQ:CME) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 2,070 shares of the financial services provider’s stock, valued at approximately $571,000.

Other large investors have also modified their holdings of the company. Webster Bank N. A. lifted its stake in CME Group by 206.9% in the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after buying an additional 60 shares in the last quarter. Highline Wealth Partners LLC raised its holdings in shares of CME Group by 84.3% in the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 43 shares during the last quarter. Sagard Holdings Management Inc. purchased a new stake in shares of CME Group in the second quarter valued at $30,000. Trifecta Capital Advisors LLC boosted its stake in shares of CME Group by 59.2% during the second quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock valued at $31,000 after acquiring an additional 42 shares during the last quarter. Finally, Ransom Advisory Ltd acquired a new stake in shares of CME Group during the first quarter valued at $31,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Stock Up 0.4%

Shares of CME opened at $273.55 on Monday. CME Group Inc. has a fifty-two week low of $224.62 and a fifty-two week high of $290.79. The company’s fifty day moving average is $271.85 and its two-hundred day moving average is $272.22. The firm has a market cap of $98.64 billion, a PE ratio of 26.51, a price-to-earnings-growth ratio of 4.08 and a beta of 0.28. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.63 by $0.05. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The business had revenue of $1.54 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same period last year, the company posted $2.68 EPS. The business’s quarterly revenue was down 3.0% on a year-over-year basis. Analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 30th. Stockholders of record on Friday, December 12th will be paid a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.8%. The ex-dividend date of this dividend is Friday, December 12th. CME Group’s payout ratio is currently 48.45%.

Insider Transactions at CME Group

In other CME Group news, Director Harold Eugene Jr. Ford sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price of $263.53, for a total transaction of $263,530.00. Following the completion of the sale, the director directly owned 1,091 shares in the company, valued at $287,511.23. The trade was a 47.82% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director William R. Shepard bought 262 shares of the business’s stock in a transaction dated Thursday, September 25th. The stock was acquired at an average cost of $265.19 per share, for a total transaction of $69,479.78. Following the purchase, the director owned 258,459 shares in the company, valued at approximately $68,540,742.21. This trade represents a 0.10% increase in their position. The SEC filing for this purchase provides additional information. Insiders have sold a total of 2,147 shares of company stock worth $562,079 over the last 90 days. Company insiders own 0.30% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have issued reports on CME. Weiss Ratings restated a “buy (b)” rating on shares of CME Group in a report on Wednesday, October 8th. Barclays upped their price objective on shares of CME Group from $280.00 to $304.00 and gave the company an “equal weight” rating in a research note on Friday. JPMorgan Chase & Co. lifted their target price on shares of CME Group from $252.00 to $256.00 and gave the stock an “underweight” rating in a research note on Tuesday, October 14th. Argus cut their price target on CME Group from $308.00 to $295.00 in a report on Friday, October 31st. Finally, TD Cowen raised their price objective on CME Group from $288.00 to $290.00 and gave the stock a “hold” rating in a report on Thursday, October 23rd. Eight research analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat, CME Group currently has an average rating of “Hold” and an average target price of $290.00.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.